Correlation Between Black Diamond and Ascendis Pharma

Can any of the company-specific risk be diversified away by investing in both Black Diamond and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Black Diamond Therapeutics and Ascendis Pharma AS, you can compare the effects of market volatilities on Black Diamond and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Ascendis Pharma.

Diversification Opportunities for Black Diamond and Ascendis Pharma

-0.03

Correlation Coefficient

Black Diamond  Ascendis Pharma

Good diversification

The 3 months correlation between Black and Ascendis is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Black Diamond i.e., Black Diamond and Ascendis Pharma go up and down completely randomly.

Pair Corralation between Black Diamond and Ascendis Pharma

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Ascendis Pharma. In addition to that, Black Diamond is 1.55 times more volatile than Ascendis Pharma AS. It trades about -0.08 of its total potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.15 per unit of volatility. If you would invest  13,207  in Ascendis Pharma AS on October 6, 2024 and sell it today you would earn a total of  833.00  from holding Ascendis Pharma AS or generate 6.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Black Diamond Therapeutics  vs.  Ascendis Pharma AS

Black Diamond Therap

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Ascendis Pharma AS

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Ascendis Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Black Diamond and Ascendis Pharma

The main advantage of trading using opposite Black Diamond and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.

The idea behind Black Diamond Therapeutics and Ascendis Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.